Merck & Co., Inc. logo

Merck & Co., Inc. (MRK)

Market Closed
15 Jun, 20:00
NYSE NYSE
$
114. 90
-4.15
-3.4859%
$
294.03B Market Cap
58.39 P/E Ratio
0.77% Div Yield
11.56M Volume
1.46 Eps
$ 119.05
Previous Close
Analysts:
Add Transaction
Day Range
114.86 118.95
Year Range
76.66 125.14
Want to track MRK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Merck's outlook for 2026 comes in lower-than-expected as pipeline faces make-or-break year

Merck's outlook for 2026 comes in lower-than-expected as pipeline faces make-or-break year

Merck's stock falls as the full-year revenue and profit outlooks were below expectations.

Marketwatch | 4 months ago
Merck Expects Slower Earnings Growth As It Spends on Acquisitions

Merck Expects Slower Earnings Growth As It Spends on Acquisitions

Merck recorded higher revenue in its fourth quarter, but expects earnings growth to slow as it ramps up acquisitions.

Wsj | 4 months ago
Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year

Merck Reports Earnings Tuesday Morning After Gaining 13% Over the Past Year

Merck & Co. reports Q4 2025 earnings on Tuesday, Feb. 3, 2026, before market open.

247wallst | 4 months ago
Merck (MRK) Advances While Market Declines: Some Information for Investors

Merck (MRK) Advances While Market Declines: Some Information for Investors

Merck (MRK) reached $110.42 at the closing of the latest trading day, reflecting a +1.92% change compared to its last close.

Zacks | 4 months ago
Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings

Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings

Merck heads into Q4 earnings with strong Keytruda demand and new product launches, but declining estimates and M&A costs cloud the near-term outlook.

Zacks | 4 months ago
Why the Market Dipped But Merck (MRK) Gained Today

Why the Market Dipped But Merck (MRK) Gained Today

Merck (MRK) closed at $108.34 in the latest trading session, marking a +1.35% move from the prior day.

Zacks | 4 months ago
Curious about Merck (MRK) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Curious about Merck (MRK) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Merck (MRK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.

Zacks | 4 months ago
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 4 months ago
Merck's Non-Oncology Drugs Q4 Performance: What to Expect

Merck's Non-Oncology Drugs Q4 Performance: What to Expect

MRK's focus shifts beyond Keytruda in Q4 as investors watch new products Capvaxive and Winrevair, as well as Animal Health business sales performance.

Zacks | 4 months ago
What's Fueling The Rally In Merck Stock?

What's Fueling The Rally In Merck Stock?

Merck (MRK)'s stock surged by 41% in the last six months, driven not only by a modest revenue increase but also by a significant profit jump and heightened investor confidence.

Forbes | 4 months ago
Brokers Suggest Investing in Merck (MRK): Read This Before Placing a Bet

Brokers Suggest Investing in Merck (MRK): Read This Before Placing a Bet

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Zacks | 4 months ago
Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 4 months ago
Loading...
Load More